These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26322868)

  • 1. Patient-Specific Induced Pluripotent Stem Cells for Disease Modeling and Phenotypic Drug Discovery.
    Tang S; Xie M; Cao N; Ding S
    J Med Chem; 2016 Jan; 59(1):2-15. PubMed ID: 26322868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
    Corti S; Faravelli I; Cardano M; Conti L
    Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new era of disease modeling and drug discovery using induced pluripotent stem cells.
    Suh W
    Arch Pharm Res; 2017 Jan; 40(1):1-12. PubMed ID: 27921262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
    Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
    Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-in-a-dish: the contribution of patient-specific induced pluripotent stem cell technology to regenerative rehabilitation.
    Mack DL; Guan X; Wagoner A; Walker SJ; Childers MK
    Am J Phys Med Rehabil; 2014 Nov; 93(11 Suppl 3):S155-68. PubMed ID: 25122102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cells: A path towards improved epilepsy therapies.
    Lybrand ZR; Goswami S; Hsieh J
    Neuropharmacology; 2020 May; 168():107781. PubMed ID: 31539537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cells in pediatric cardiology.
    Patel P; Mital S
    Eur J Pediatr; 2013 Oct; 172(10):1287-92. PubMed ID: 23292032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concise review: Embryonic stem cells versus induced pluripotent stem cells: the game is on.
    Puri MC; Nagy A
    Stem Cells; 2012 Jan; 30(1):10-4. PubMed ID: 22102565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced pluripotent stem cells as cardiac arrhythmic in vitro models and the impact for drug discovery.
    Sarić T; Halbach M; Khalil M; Er F
    Expert Opin Drug Discov; 2014 Jan; 9(1):55-76. PubMed ID: 24294840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced pluripotent stem cell-based studies of Parkinson's disease: challenges and promises.
    Sanchez-Danes A; Benzoni P; Memo M; Dell'Era P; Raya A; Consiglio A
    CNS Neurol Disord Drug Targets; 2013 Dec; 12(8):1114-27. PubMed ID: 24040813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concise Review: Induced Pluripotent Stem Cell-Based Drug Discovery for Mitochondrial Disease.
    Inak G; Lorenz C; Lisowski P; Zink A; Mlody B; Prigione A
    Stem Cells; 2017 Jul; 35(7):1655-1662. PubMed ID: 28544378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of induced pluripotent stem cells in drug development.
    Inoue H; Yamanaka S
    Clin Pharmacol Ther; 2011 May; 89(5):655-61. PubMed ID: 21430656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. iPS cell derived neuronal cells for drug discovery.
    Heilker R; Traub S; Reinhardt P; Schöler HR; Sterneckert J
    Trends Pharmacol Sci; 2014 Oct; 35(10):510-9. PubMed ID: 25096281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concise review: modeling central nervous system diseases using induced pluripotent stem cells.
    Zeng X; Hunsberger JG; Simeonov A; Malik N; Pei Y; Rao M
    Stem Cells Transl Med; 2014 Dec; 3(12):1418-28. PubMed ID: 25368377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases.
    Payne NL; Sylvain A; O'Brien C; Herszfeld D; Sun G; Bernard CC
    N Biotechnol; 2015 Jan; 32(1):212-28. PubMed ID: 24815224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced pluripotent stem cell research: a revolutionary approach to face the challenges in drug screening.
    Song M; Paul S; Lim H; Dayem AA; Cho SG
    Arch Pharm Res; 2012 Feb; 35(2):245-60. PubMed ID: 22370779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human pluripotent stem cell-derived models and drug screening in CNS precision medicine.
    Silva MC; Haggarty SJ
    Ann N Y Acad Sci; 2020 Jul; 1471(1):18-56. PubMed ID: 30875083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A low-cost, high-quality new drug discovery process using patient-derived induced pluripotent stem cells.
    Giri S; Bader A
    Drug Discov Today; 2015 Jan; 20(1):37-49. PubMed ID: 25448756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and opportunities toward enabling phenotypic screening of complex and 3D cell models.
    Horman SR; Hogan C; Delos Reyes K; Lo F; Antczak C
    Future Med Chem; 2015; 7(4):513-25. PubMed ID: 25875876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cells for disease modeling, cell therapy and drug discovery in genetic autonomic disorders: a review.
    Saito-Diaz K; Zeltner N
    Clin Auton Res; 2019 Aug; 29(4):367-384. PubMed ID: 30631982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.